US Patent 8993266 Proproteins activatable interferon alpha
Patent 8993266 was granted and assigned to CytomX Therapeutics on March, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8993266 Proproteins activatable interferon alpha
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.